Betekenis van:
infectious agent
infectious agent
Zelfstandig naamwoord
- an agent capable of producing infection
Synoniemen
Hyperoniemen
Hyponiemen
Voorbeeldzinnen
- Anti-infectious agent
- NO ENTRY Anti-infectious agent
- Not for use in animals from which eggs are produced for human consumption. Anti-infectious agents/Antibiotics Oxalic acid NOT APPLICABLE Bees No MRL required NOT APPLICABLE NO ENTRY Anti-infectious agent Oxfendazole
- treat all effluents and wastes generated within the quarantine unit in a manner that effectively inactivates the infectious agent responsible for the relevant listed disease(s);
- water in the quarantine units concerned is treated in a manner that effectively inactivates the infectious agent responsible for the relevant listed disease(s).
- Upon receipt, transport vehicles and equipment, including tanks, containers and water must be treated in a manner that effectively inactivates the infectious agent responsible for the relevant listed disease(s).
- When the official veterinarian, while carrying out ante-mortem or post-mortem inspection or any other inspection activity, suspects the presence of an infectious agent mentioned on OIE List A or, where appropriate, OIE List B, the official veterinarian must immediately notify the competent authority and both must take all necessary measures and precautions to prevent the possible spread of the infectious agent in accordance with applicable Community legislation.
- ‘The holder of the marketing authorisation for a medicinal product for human use shall ensure that all suspected serious unexpected adverse reactions and any suspected transmission via a medicinal product of any infectious agent occurring in the territory of a third country are reported promptly to Member States and the Agency, and no later than 15 days following receipt of the information.
- ‘The holder of the marketing authorisation for a veterinary medicinal product shall ensure that all suspected serious unexpected adverse reactions, and adverse human reactions, and any suspected transmission via a medicinal product of any infectious agent occurring in the territory of a third country are reported promptly to the Member States and the Agency, and no later than 15 days following receipt of the information.